Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) is getting a small boost this side of the pond, with traders adding about 0.2% to its share price today in modest trading volume after the company forecast 6 percent to 8 percent revenue growth in 2011.
That topped the $12.74 billion average of nine analyst polled by Zacks by at least $60 million this year. Fresenius said earlier today it expects revenue to grow to a range between $12.8 billion to $13.0 billion.
Net income is expected to be $10 million to either side of $1.045 billion, Fresenius officials said. That works out to a mid-range earnings call of about $3.46 a share, below the $3.56 EPS consensus.
Fresenius shares closed up about 1.4 percent higher earlier today in Frankfurt trading after reporting a $0.90 a share Q4 profit on $3.17 billion in sales, beating the Street view by $0.02.